Topics

Glioblastoma | Treatment | Clinical trials | Belzutifan

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Belzutifan

Strowd RE, de la Fuente M, Bauer TM, Papadopoulos KP, Chen K, Perini RF, Liu Y, McDermott DF.
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort.
Neurooncol Adv. 2025 Nov 20;8(1):vdaf242. doi: 10.1093/noajnl/vdaf242. PMID: 42058763. Trial registration ID: NCT02974738. ˍ